W. Wang et al., INACTIVATION OF INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE BY THE ANTIVIRAL AGENT YNYL-1-BETA-D-RIBOFURANOSYLIMIDAZOLE-4-CARBOXAMIDE 5'-MONOPHOSPHATE, Biochemistry, 35(1), 1996, pp. 95-101
Inosine 5'-monophosphate dehydrogenase (IMPDH) is the rate-limiting en
zyme in de novo guanine nucleotide biosynthesis, IMPDH converts inosin
e 5'-monophosphate (IMP) to xanthosine 5'-monophosphate (XMP) with con
comitant conversion of NAD(+) to NADH. The antiviral agent ynyl-1-beta
-D-ribofuranosylimidazole-4-carboxamide (EICAR) is believed to inhibit
IMPDH by forming an active metabolite, the 5'-monophosphate EICARMP.
The experiments reported here demonstrate that EICARMP irreversibly in
activates both human type II and Escherichia coli IMPDH, IMPDH is prot
ected from EICARMP inactivation by IMP, but not by NAD(+). Further, de
naturation/renaturation of the EICARMP-inactivated enzyme did not rest
ore enzyme activity, which indicates that EICARMP forms a covalent add
uct with IMPDH. EICARMP was successfully used to titrate the active si
tes of IMPDH; these experiments demonstrate that four active sites are
present in an IMPDH tetramer, Matrix-assisted laser desorption ioniza
tion time-of-flight (MALDI-TOF) mass spectrometry of native E. coli IM
PDH established that protein translation initiates at the third ATG of
the DNA sequence. Thus, the E. coli IMPDH monomer is only 488 amino a
cids long and contains five instead of six cysteines. In addition, MAL
DI-TOF mass spectrometry showed that EICARMP is covalently bound to Cy
s-305 (Cys-331 in human type II IMPDH numbering), suggesting that Cys-
305 functions as a nucleophile in the IMPDH reaction, The inactivation
of the E. coli enzyme is a single-step reaction with k(on) = 1.94 x 1
0(4) M(-1) s(-1). In contrast, the inactivation of human type II IMPDH
involves a two-step mechanism where K-i = 16 mu M, k(2) = 2.7 x 10(-2
) s(-1) and k(on) = 1.7 x 10(3) M(-1) s(-1). These results demonstrate
that significant differences exist between bacterial and human IMPDH
and suggest that this enzyme may be a target for antibiotic drugs.